Title	Efficacy
Number of Patients Screened	15
Number of Patients Enrolled	15
Number of Patients Evaluable for Toxicity	15
Number of Patients Evaluated for Efficacy	13
Evaluation Method	RECIST version 1.1
Response Assessment CR	n = 0 (0%)
Response Assessment PR	n = 1 (6.7%)
Response Assessment SD	n = 5 (33.3%)
Response Assessment PD	n = 7 (46.7%)
Response Assessment OTHER	n = 0 (0%)
(Median) Duration Assessments PFS	1.8 months; 95% CI, 1.7–4.7.